. DNA synthesis is inhibited by CLB in A204 cells. A204 cells were synchronized and treated with 0, 10 and 100 µM CLB for 12 h. Cells were labeled with BrdU, fixed and stained with anti-BrdU, and then with Alexa 488-conjugated secondary antibody (green).
DAPI was used to visualize the nucleus (blue). BrdU incorporation was quantified and reported as mean ± SD (n = 5-12). **, p < 0.01; ***, p < 0.001. Figure S3 . Knockdown of β2-AR by siRNA.
β2-AR (si-AR) and control siRNA (siNC) were transiently transfected into synchronized cells, which were then cultured for 60 h in the presence of 100 µM CLB. β2-AR was analyzed by western blot, using GAPDH as loading control. Fold expression change is indicated below blots. Figure S4. Knockdown of β-arrestin 1 and 2 by shRNA. (A) -(B) Cells were transiently transfected with shRNA for β-arrestin 1 and 2 (sh-Arrb1 and sh-Arrb2, respectively). sh-NC was used as control. Expression of β-arrestin 1 and 2 was measured by western blot, using GAPDH as internal control. Fold expression change is indicated below blots. (C) Abundance of Skp2 mRNA does not change significantly with CLB treatment. C2C12 cells were treated with 0 or 100 µM CLB for 24 h, and abundance of Skp2 mRNA was analyzed by real-time PCR. Results are mean ± SD (n = 3).
